Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+3.4M
-
Total reported value, excl. options
-
$449M
-
Value change
-
+$65.9M
-
Number of buys
-
71
-
Number of sells
-
-21
-
Price
-
$18.22
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2021
105 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q1 2021.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 127M outstanding shares and own 19.41% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3M shares), BlackRock Inc. (2.29M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.01M shares), VANGUARD GROUP INC (1.54M shares), PURA VIDA INVESTMENTS, LLC (1.51M shares), Avidity Partners Management LP (1.46M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.4M shares), Nuveen Asset Management, LLC (966K shares), Assenagon Asset Management S.A. (903K shares), and GEODE CAPITAL MANAGEMENT, LLC (730K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.